Association between aldosterone synthase (CYP11B2) polymorphism and left ventricular mass in human essential hypertension

Journal of the American College of Cardiology

Volumn 43, Issue 2, 2004, Pages 265-270

  Stella, Paola ^a   Bigatti, Giada ^b   Tizzoni, Laura ^a   Barlassina, Cristina ^b   Lanzani, Chiara ^a   Bianchi, Giuseppe ^a   Cusi, Daniele ^b  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE SYNTHASE; RNA;

ADULT; AGE DISTRIBUTION; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; BODY MASS; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME ACTIVITY; ENZYME POLYMORPHISM; ESSENTIAL HYPERTENSION; FEMALE; FIBROSIS; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART MUSCLE FIBROSIS; HEART RATE; HEART SIZE; HEART VENTRICLE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE WALL; HORMONE ACTION; HORMONE SYNTHESIS; HUMAN; HYPERTENSION; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PATHOLOGY; PRIORITY JOURNAL; PROMOTER REGION; SEX DIFFERENCE;

EID: 1042275834     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2003.08.034     Document Type: Article

References (28)

1. Levy D., Garrison R.J., Savage D.D., et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 322:1990;1561-1566.
2. Lauer M.S., Evans J.C., Levy D. Prognostic implications of subclinical left ventricular dilatation and systolic dysfunction in men free of overt cardiovascular disease (the Framingham Heart Study). Am J Cardiol. 70:1992;1180-1184.
3. Devereux R.B., Roman M.J. Hypertensive cardiac hypertrophy: pathophysiologic and clinical characteristics. Laragh J.H., Brenner B.M. Hypertension: Pathophysiology, Diagnosis and Management. 2nd ed:1995;409-432 Raven, New York, NY.
4. Schmieder R.E., Martus P., Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension a meta-analysis of randomized double-blind studies . JAMA. 275:1996;1507-1513.
5. Kaplan N.M. Systemic hypertension: mechanisms and diagnosis. Braunwald E. Heart Disease. 5th ed:1997;807-839 Saunders, Philadelphia, PA.
6. Brilla C.G., Pick R., Tan L.B., et al. Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res. 67:1990;1355-1364.
7. Robert V., Nguyen V.T., Cheav S.L., et al. Increased cardiac types I and III collagen mRNAs in aldosterone-salt hypertension. Hypertension. 24:1994;30-36.
8. Young M., Fullerton M., Dilley R., et al. Mineralcorticoids, hypertension, and cardiac fibrosis. J Clin Invest. 93:1994;2578-2583.
9. Pitt B., Zannad F., Remme W.J., et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 341:1999;709-717.
10. Delcayre C., Silvestre J.B., Oubenaissa A., et al. Cardiac aldosterone production and ventricular remodeling. Kidney Int. 57:2000;1346-1351.
11. Satoh M., Nakamura M., Saitoh H. Aldosterone synthase (CYP11B2) expression and myocardial fibrosis in the failing human heart. Clin Sci (Colch). 102:2002;381-386.
12. Yamamoto N., Yasue H., Mizuno Y., et al. Aldosterone is produced from ventricles in patients with essential hypertension. Hypertension. 39:2002;958-962.
13. Brand E., Schorr U., Ringel J., et al. Aldosterone synthase gene (CYP11B2) C-344T polymorphism in Caucasians from the Berlin Salt-Sensitivity Trial (BeSST). J Hypertens. 17:1999;1563-1567.
14. Kupari M., Hautanen A., Lankinen L., et al. Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function. Circulation. 97:1998;569-575.
15. Tamaki S., Iwai N., Tsujita Y., et al. Genetic polymorphism of CYP11B2 gene and hypertension in Japanese. Hypertension. 33:(Pt II):1999;266-270.
16. Schunkert H., Hengstenberg C., Holmer S.R., et al. Lack of association between a polymorphism of the aldosterone synthase gene and left ventricular structure. Circulation. 99:1999;2255-2260.
17. Delles C., Erdmann J., Jacobi J., et al. Aldosterone synthase (CYP11B2)-344C/T polymorphism is associated with left ventricular structure in human arterial hypertension. J Am Coll Cardiol. 37:2001;878-884.
18. Sahn D.J., De Maria A., Kisslo J., et al. the Committee on M-Mode Standardization of the American Society of Echocardiography. Recommendations regarding quantitation in M-mode echocardiography result of a survey of echocardiographic measurements . Circulation. 58:1978;1072-1083.
19. Liu K., Stamler J., Dyler A., et al. Statistical methods to assess and minimize the role of intra-individual variability in obscuring the relationship between dietary lipids and serum cholesterol. J Chron Dis. 31:1978;399-418.
20. Devereux R.B., Reichek N. Echocardiographic determination of left ventricular mass in man. Circulation. 55:1977;613-618.
21. Devereux R.B., Alonso D.R., Lutas E.M., et al. Echocardiographic assessment of left ventricular hypertrophy comparison to necropsy findings . Am J Cardiol. 57:1986;450-458.
22. Ganau A., Devereux R.B., Roman M.J., et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol. 19:1992;1550-1558.
23. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;CSH Press, Cold Spring Harbor, NY.
24. Livak K.J., Flood S.J., Marmaro J., et al. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. PCR Methods Appl. 4:1995;357-362.
25. Guyton A.C. Dominant role of the kidney and accessory role of whole-body autoregulation in the pathogenesis of hypertension. Am J Hypertens. 2:1989;575-585.
26. Brand E., Chatelain N., Mulatero P., et al. Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension. 32:1998;198-204.
27. Davies E., Holloway C.D., Ingram M.C., et al. Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2. Hypertension. 33:1999;703-707.
28. Pojoga L., Gautier S., Blanc H., et al. Genetic determination of plasma aldosterone in essential hypertension. Am J Hypertens. 11:1998;856-860.